Determinants of Chronic Inflammatory Skin Disease Trajectories

Sponsor
University Hospital Schleswig-Holstein
Study ID
NCT05928169
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
0 Years - 80 Years
Healthy Volunteers
Accepted

Interventions

  • Topical and systemic drugs — DRUG
    Recruitment and follow-up will be independent on the type of treatment

Study Details

Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiological data on this, and the factors that determine the manifestation, clinical features and course are also largely unknown. There are currently no reliable markers that could predict or delineate patient subgroups to support patient management. The aim of this project is to identify clinical and molecular factors that correlate with disease, disease subtypes and progression through in-depth long-term clinical characterization of patients with chronic inflammatory skin diseases and examination of individual biomaterials.

Key Dates

First listed
Jul 3, 2023
Start date
May 1, 2023
Status verified
Jul 2025
Primary completion
Apr 30, 2032
Completion
Dec 31, 2032

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Physician-assessed global disease activity [ Time Frame: Baseline, week 2, week 4, every 3 months up to 2 years ]

Central Contacts

Find similar trials

Nationwide
Atopic dermatitis / eczema trialsLupus (SLE) trialsHidradenitis suppurativa trialsPsoriasis trialsDermatology trialsRheumatology trialsAutoimmune disease trials

Related Studies